Robotic Microcapsule Assemblies with Magnetic Actuation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current targeted medical treatments face challenges in directed mobility, limited payload capacity, and ineffective drug delivery due to passive delivery systems that fail to reach target sites without active propulsion, leading to poor drug protection and denaturation or leakage.
Innovation Solution
The development of robotic microcapsules with a magnetic system that includes iron oxide nanoparticles, allowing for precise control and navigation to target areas, enabling high drug loading and protection, and overcoming physical barriers for controlled release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If passive delivery systems like liposomes and micelles are used, then drug protection is provided, but directed mobility and navigation to target sites are limited
Solution Approach 1:
The patent replaces passive diffusion-based mechanical transport with active magnetic field-controlled propulsion. Iron oxide nanoparticles embedded in the microcapsule shell enable magnetic actuation, allowing external magnetic fields to drive the microcapsules to target sites actively rather than relying on passive fluid circulation and diffusion.
Solution Approach 2:
The microcapsules are constructed as composite structures combining iron oxide nanoparticles with protective shell materials. This composite design integrates both drug protection capabilities from the shell and active magnetic propulsion from the iron oxide particles, resolving the contradiction between protection and mobility.
2Reliability
If surface coating or grafting is used for cargo loading, then drug protection is achieved, but payload volume and release effectiveness are limited
Solution Approach 1:
The patent employs a nested encapsulation structure where therapeutic agents are enclosed within the microcapsule core, which is itself surrounded by a protective shell containing iron oxide nanoparticles. This nested design allows high payload volume while maintaining drug protection through the encapsulation barrier.
Solution Approach 2:
The microcapsule shell is designed as a flexible thin film structure that encapsulates the therapeutic payload. This shell provides drug protection while allowing controlled release through its permeable or degradable properties, overcoming the limitations of rigid surface coating approaches.
3Ease of manufacture
If therapeutic agents are mixed with precursors before building robots, then robot construction is simplified, but drug denaturation or leakage occurs
Solution Approach 1:
The patent separates the manufacturing process into distinct stages: first, the microcapsule structure with iron oxide nanoparticles is constructed; then, the therapeutic payload is loaded into the pre-formed capsules. This preliminary structuring prevents direct contact between drugs and potentially denaturing precursors during construction, maintaining drug stability while simplifying overall manufacturing.
Solution Approach 2:
The manufacturing process is segmented into independent modules: capsule shell formation, iron oxide nanoparticle integration, and therapeutic payload loading. This segmentation allows each component to be optimized separately, ensuring drug stability during construction while maintaining ease of manufacture through modular assembly.
4Adaptability or versatility
If microcapsules form chain-like assemblies, then ability to overcome physical barriers is improved, but system complexity increases
Solution Approach 1:
The patent combines multiple microcapsules into chain-like assemblies that work together as a unified system. The iron oxide nanoparticles in each capsule respond collectively to external magnetic fields, enabling the assembly to overcome physical barriers through coordinated magnetic actuation while maintaining relatively simple individual capsule structures.
Solution Approach 2:
The microcapsule assemblies are designed to be dynamic and reconfigurable, allowing them to adapt their chain structure in response to magnetic field gradients and physical barriers. This dynamic behavior enables barrier overcoming capability without requiring complex predetermined structures, as the assemblies self-organize under magnetic actuation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system achieves precise and effective delivery of therapeutic agents to target sites with high drug protection and mobility, overcoming physical and biological barriers, and ensuring controlled release without cytotoxicity or damage to biological cells.
Implementation Method 1
The magnetic system can be configured to generate a magnetic field to control a motion of the at least one microcapsule
Implementation Method 2
The at least one microcapsule can include the therapeutic agent and a layer of iron oxide nanoparticles (IONPs)
Data Source
AI summary
The disclosed subject matter provides systems and methods for delivering a therapeutic agent for targeted treatments. The system can include at least one microcapsule and a magnetic system. The microcapsule can include the therapeutic agent and a layer of iron oxide nanoparticles (IONPs). The therapeutic agent can be encapsulated by the layer of the IONPs that include a first type of nanoparticles and a second type of nanoparticles. The magnetic system can be configured to generate a magnetic field to control the motion of the microcapsule as well as to assemble into multi-capsule structure and control its motion. Assemblies of multiple microcapsules can be controlled simultaneously and directed to targeted areas for delivery of larger therapeutic payload.